Singapore markets close in 5 hours 58 minutes
Straits Times Index
3,289.28 +23.33 (+0.71%) Nikkei
38,311.63 +237.65 (+0.62%) Hang Seng
18,793.23 +255.42 (+1.38%) FTSE 100
8,381.35 +27.30 (+0.33%) Bitcoin USD
62,879.40 +1,242.28 (+2.02%) CMC Crypto 200
1,352.72 +52.62 (+4.05%)
Ocean Biomedical, Inc. (OCEA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 60.64M |
| Enterprise value | 72.66M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 100.67 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.90 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.64 |
| 52-week change 3 | -70.71% |
| S&P500 52-week change 3 | 26.43% |
| 52-week high 3 | 12.0800 |
| 52-week low 3 | 0.5200 |
| 50-day moving average 3 | 2.8668 |
| 200-day moving average 3 | 2.3042 |
Share statistics
| Avg vol (3-month) 3 | 6.98M |
| Avg vol (10-day) 3 | 509.08k |
| Shares outstanding 5 | 34.65M |
| Implied shares outstanding 6 | 34.65M |
| Float 8 | 3.72M |
| % held by insiders 1 | 71.99% |
| % held by institutions 1 | 13.54% |
| Shares short (15 Apr 2024) 4 | 643.94k |
| Short ratio (15 Apr 2024) 4 | 1.07 |
| Short % of float (15 Apr 2024) 4 | 6.31% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.86% |
| Shares short (prior month 15 Mar 2024) 4 | 873.36k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -681.99% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -98.59M |
| Diluted EPS (ttm) | -3.0000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 31k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 17.16M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.03 |
| Book value per share (mrq) | -2.21 |
Cash flow statement
| Operating cash flow (ttm) | -8.6M |
| Levered free cash flow (ttm) | 1.56M |
© 2024 Yahoo. All rights reserved.